Machine Learning

AI agents connect to your most critical systems, creating hidden risks. A new class of security tools aims to map and neutralize these invisible threats.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

How a super-regional insurer's full-scale cloud modernization with Guidewire is a strategic move to boost agility and precision in challenging markets.

ADP's new retirement plan isn't just about lower fees. It's a tech-driven strategy to solve the SMB benefits gap and empower financial advisors.

A crypto fund's nomination for a top award signals a new era for family offices seeking managed risk and high returns in the volatile digital asset market.

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

Ontario's new FAST program speeds access to cancer drugs like Scemblix, challenging Canada's slow reimbursement system. Is this a new national blueprint?

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

The ESA's new elite summit, iicon, replaces E3, targeting C-suites to leverage gaming tech across healthcare, finance, and media. What's at stake?

Early Phase 1 data for VTP-1000 shows promise, but can this novel immunotherapy challenge a crowded market and change life for 80 million patients?

New data shows Kazia's paxalisib dismantles metastatic drivers and reignites immunity, signaling a strategic disruption in advanced breast cancer treatment.

A new, fully customizable quantum system promises to democratize R&D, fueling national strategies and accelerating discovery in science and medicine.

CodeSignal's new AI interviews candidates by phone in 20+ languages, promising a revolution in efficiency. But can it overcome the hurdles of bias and empathy?

A new partnership between Telix and Varian aims to fuse precision diagnostics with adaptive radiotherapy, a strategic move set to disrupt the cancer care market.

A new contract for specialized titanium powder signals a major shift in manufacturing, securing critical supply chains for a booming $1.4B market.

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

A Canadian youth sports leader's entry into India reveals a blueprint for AI-driven physical literacy and a new paradigm for children's healthcare.

Professor Youmin Xi's recent honor signals more than academic success. It marks a strategic blueprint for cultivating the next generation of life science leaders.